INOZYME PHARMA, INC. Employee-related Liabilities, Current
INOZYME PHARMA, INC. had Employee-related Liabilities, Current of $3.67 million as of 2024-12-31, per its 10-K filed 2025-03-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:EmployeeRelatedLiabilitiesCurrent · last filed 2025-03-10
- 2024-12-31: Employee-related Liabilities, Current $3.67M.
- 2023-12-31: Employee-related Liabilities, Current $3.84M.
- 2023-06-30: Employee-related Liabilities, Current $2.68M.
- 2023-03-31: Employee-related Liabilities, Current $2.03M.
| Period end | Employee-related Liabilities, Current | Employee-related Liabilities, Current as first filed |
|---|---|---|
| 2024-12-31 | $3.67M 10-K · filed 2025-03-10 | |
| 2023-12-31 | $3.84M 10-K · filed 2025-03-10 | |
| 2023-06-30 | $2.68M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $2.03M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $3.23M 10-K · filed 2024-03-12 | $2.80M 10-K · filed 2023-03-22 |
| 2022-09-30 | $2.26M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.68M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $750.00K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $2.38M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $1.91M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $1.45M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $1.12M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $2.30M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $1.36M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $736.00K 10-Q · filed 2020-09-03 | |
| 2019-12-31 | $861.00K 10-K · filed 2021-03-25 |